Archive

Latest California Healthline Stories

Financial Ties That Bind: Studies Often Fall Short On Conflict-Of-Interest Disclosures

A new study in JAMA Surgery finds that a large sample of published medical research failed to disclose details on the financial relationships between medical device makers and physicians. Changes in the disclosure process could close this loop.

Voters To Settle Dispute Over Ambulance Employee Break Times

Unlike most other workers, private-ambulance employees are frequently called away from their meals and rest breaks to respond to emergency calls, but there’s no law explicitly allowing that practice. Proposition 11 would change that, but some say its real purpose is to get California’s largest ambulance company out of costly litigation.

‘No One Is Ever Really Ready’: Aid-In-Dying Patient Chooses His Last Day

With its expansion to Hawaii this year, medical aid-in-dying is now approved in eight U.S. jurisdictions. Even when legal, the controversial practice of choosing to die after a terminal diagnosis is difficult, said one Seattle man who shared his final deliberations.

Battle Lines Drawn As Abortion-Rights Activists Leave Their Mark Outside Clinics

Armed with poster board and catchy advertising slogans, abortion-rights activists in California and elsewhere are taking to sidewalks, buses and mobile phone apps to fight a recent U.S. Supreme Court ruling in favor of crisis pregnancy centers.

Clinicians Who Learn Of A Patient’s Opioid Death Modestly Cut Back On Prescriptions

A study published Thursday shows that doctors, dentists and other medical providers cut overall opioid dosages by nearly 10 percent after receiving notification of a death from a medical examiner and information on safe prescribing.

Podcast: KHN’s ‘What The Health?’ Coming Soon: ‘Long-Term Short-Term’ Plans

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner talk about the latest Trump administration efforts to address high drug prices, what’s next for short-term health insurance plans and insider trading charges against a New York GOP congressman.